When it comes to alternative and natural products, individuals need to be cautious as some are safer than others. For example, while a CBD anxiety wellbeing health plan can be a good option, there are other natural products which can cause more harm than good. As such, it is important to know whether any natural product, including CBD products have the potential to interact with OTC products or prescription medications.
When it comes to CBD, it is a compound originally discovered in 1940 in what is better known as the cannabis or hemp plant. CBD extract comes from the cannabis plant, the same plant which produces THC found in marijuana. While this is the case, there have been over one hundred different cannabinoids found in the cannabis or hemp plant, including hemp extract. To date, CBD oil has been proven effective in relieving pain and treating epilepsy, movement disorders and anxiety.
CBD can be imbibed in multiple ways, the most efficient of which is placing drops of oil under the tongue. Whereas, individuals can also eat, drink, smoke and vape as well as use salves for burns and muscle pain. Some edible products include coffee beans, gummies, honey sticks and cough drops. Whereas, there are also soft drinks and other consumable liquids which contain CBD.
CBD is currently available with or without traces of THC. For, one version contains CBD as the active ingredient with no trace of THC. Whereas, the other version contains trace amounts of THC while CBD remains the active ingredient.
While the drug Epidiolex which contains CBD oil has received a green light for marketing from the United States FDA, there remains some confusion as to the full legality of CBD products. In addition, there can be minimal side effects depending on the length of use and potency of the product. While these can include a loss of appetite, diarrhea, fatigue, malaise, weakness and sleeping problems, these are minimal compared to side-effects associated with medications which contain opioids.
Currently, the United States FDA has labeled Epidiolex as a Schedule V drug. While non-Epidiolex CBD still remains a Schedule I drug prohibited for use in many areas. Regardless, stores across the United States are now selling CBD oil and products on the open market. Whereas, the United Nations has not scheduled CBD under any drug control treaties and World Health Organization officials have recommended that the drug remain unclassified or scheduled.
While there are few side effects compared to opioids and other narcotics, the potential of interactions with pharmaceuticals or over the counter drugs remain widely unknown. While this is the case, it is suspected that due to the potency of the extract, it could slow down the process of other medications. As far as dangerous interactions, at this point and time, none have been reported through research studies or use of CBD products.
As with marijuana, the prescription form of CBD is much stronger than the products currently being sold on the open market. One such drug, Nabiximols contains equal portions of THC and CBD. Considered an aspect of medical marijuana, the drug was approved by Health Canada in 2005 in the treatment of MS. Whereas, in 2007, the drug received approval from Health Canada for use in cancer patients for pain associated with the disease. Since that time, cannabinoids have been shown to kill cancer cells, as such the drugs are also being used in an attempt to stop Cancer metastasis in cancer patients.
When it comes to CBD, it is a compound originally discovered in 1940 in what is better known as the cannabis or hemp plant. CBD extract comes from the cannabis plant, the same plant which produces THC found in marijuana. While this is the case, there have been over one hundred different cannabinoids found in the cannabis or hemp plant, including hemp extract. To date, CBD oil has been proven effective in relieving pain and treating epilepsy, movement disorders and anxiety.
CBD can be imbibed in multiple ways, the most efficient of which is placing drops of oil under the tongue. Whereas, individuals can also eat, drink, smoke and vape as well as use salves for burns and muscle pain. Some edible products include coffee beans, gummies, honey sticks and cough drops. Whereas, there are also soft drinks and other consumable liquids which contain CBD.
CBD is currently available with or without traces of THC. For, one version contains CBD as the active ingredient with no trace of THC. Whereas, the other version contains trace amounts of THC while CBD remains the active ingredient.
While the drug Epidiolex which contains CBD oil has received a green light for marketing from the United States FDA, there remains some confusion as to the full legality of CBD products. In addition, there can be minimal side effects depending on the length of use and potency of the product. While these can include a loss of appetite, diarrhea, fatigue, malaise, weakness and sleeping problems, these are minimal compared to side-effects associated with medications which contain opioids.
Currently, the United States FDA has labeled Epidiolex as a Schedule V drug. While non-Epidiolex CBD still remains a Schedule I drug prohibited for use in many areas. Regardless, stores across the United States are now selling CBD oil and products on the open market. Whereas, the United Nations has not scheduled CBD under any drug control treaties and World Health Organization officials have recommended that the drug remain unclassified or scheduled.
While there are few side effects compared to opioids and other narcotics, the potential of interactions with pharmaceuticals or over the counter drugs remain widely unknown. While this is the case, it is suspected that due to the potency of the extract, it could slow down the process of other medications. As far as dangerous interactions, at this point and time, none have been reported through research studies or use of CBD products.
As with marijuana, the prescription form of CBD is much stronger than the products currently being sold on the open market. One such drug, Nabiximols contains equal portions of THC and CBD. Considered an aspect of medical marijuana, the drug was approved by Health Canada in 2005 in the treatment of MS. Whereas, in 2007, the drug received approval from Health Canada for use in cancer patients for pain associated with the disease. Since that time, cannabinoids have been shown to kill cancer cells, as such the drugs are also being used in an attempt to stop Cancer metastasis in cancer patients.
About the Author:
Our alternative health blog reveals how CBD anxiety wellbeing can make a difference to your life. Read the newly published articles online at http://www.thebotanicalwonders.com.
No comments:
Post a Comment